New drug delays progression of glioma, a deadly brain cancer
A study co-led by UCLA is the first clinical trial analyzing a targeted therapy specifically developed to treat brain tumors.
Source: ucla.edu
Page 3 - Ingo Mellinghoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ingo Mellinghoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ingo Mellinghoff Today - Breaking & Trending Today
Servier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual Grade 2 IDH-Mutant Diffuse Glioma
Vorasidenib demonstrated an unprecedented improvement in progression free survival with a median of 27.7 months in patients with residual or recurrent grade 2...
Source: prnewswire.com
Drug Delays Progression of Deadly Brain Cancer Glioma
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Source: miragenews.com
Servier's experimental drug slows deadly brain tumor in trial
Kansascity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kansascity.com Daily Mail and Mail on Sunday newspapers.
Source: kansascity.com
In Key Study, Servier Drug Delays Brain Cancer in Patients With Few Treatment Options
A Servier drug candidate acquired as part of a $1.8 billion deal kept a particular type of brain cancer from progressing in a Phase 3 clinical trial. The study results were presented during the 2023 annual meeting of the American Society of Clinical Oncology.
Source: medcitynews.com